DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1672142
Singapore, U0
Position in TEVA
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,032,800
-$979,200 QoQ
Shares Held
60,000
-40.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#265
of 671 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. holds $2,715,505 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (74.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
60,000 | $2,032,800 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,260 | $682,705 |
All Filings in TEVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,032,800 | 60,000 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $3,012,000 | 100,000 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||